Hepatocellular carcinoma: the point of view of the hepatitis B virus (Q37888329)

24 August 2017

1 reference

title

Hepatocellular carcinoma: the point of view of the hepatitis B virus (English)

1 reference

24 August 2017

1 reference

hepatocellular carcinoma

1 reference

1 reference

1

Teresa Pollicino

1 reference

24 August 2017

Carlo Saitta

2

1 reference

24 August 2017

Giovanni Raimondo

series ordinal

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

10 June 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

32

1 reference

24 August 2017

issue

8

1 reference

24 August 2017

page(s)

1122-1132

1 reference

The Hepatitis-B Virus and Hepatocellular Carcinoma

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Age distribution of histologic types of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Molecular viral oncology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Chronic hepatitis B in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus-induced oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Pathogenesis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Statements from the Taormina expert meeting on occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

A virus in Beechey ground squirrels that is related to hepatitis B virus of humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatocellular carcinoma in Richardson's ground squirrels (Spermophilus richardsonii): evidence for association with hepatitis B-like virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus infection--natural history and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus induced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus genetic variability and evolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Genetic variability in hepatitis B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatocellular carcinoma and hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus genotype and mutants: risk factors for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus genotype C takes a more aggressive disease course than hepatitis B virus genotype B in hepatitis B e antigen-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus preC mutants in human hepatocellular carcinoma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Molecular characterization of hepatitis B virus surface antigen mutants in Singapore patients with hepatocellular carcinoma and hepatitis B virus carriers negative for HBsAg but positive for anti-HBs and anti-HBc

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Specific mutations of hepatitis B virus in plasma predict liver cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Reduced antigen production by hepatitis B virus harbouring nucleotide deletions in the overlapping X gene and precore-core promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Biologic Properties of Hepatitis B Viral Genomes with Mutations in the Precore Promoter and Precore Open Reading Frame

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Effect of basal core promoter and pre-core mutations on hepatitis B virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Functional analysis of HBV genomes from patients with fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus X gene 1751 to 1764 mutations: implications for HBeAg status and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Mutation of nucleotide 1,762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Replication of hepatitis B virus in a hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Infectious agents and cancer: criteria for a causal relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Consistently low hepatitis B virus DNA saves patients from hepatocellular carcinogenesis in HBV-related cirrhosis. A nested case-control study using 96 untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

A transgenic mouse model of the chronic hepatitis B surface antigen carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Transgenic mouse models of hepatitis B virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Immunopathogenesis of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Immunopathogenesis: role of innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice†

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatic preneoplasia in hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

The IGF axis and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Molecular mechanisms in hepatocellular carcinoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepadnaviral X Protein:Review of Recent Progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Extensive analysis of duplicated-inverted hepatitis B virus integrations in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Oncogenic activation of a human cyclin A2 targeted to the endoplasmic reticulum upon Hepatitis B virus genome insertion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

A hepatitis B virus pre-S-retinoic acid receptor beta chimera transforms erythrocytic progenitor cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus DNA integration and expression of an erb B-like gene in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Enzymatic properties of overexpressed HBV-mevalonate kinase fusion proteins and mevalonate kinase proteins in the human hepatoma cell line PLC/PRF/5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

HBx M130K and V131I (T-A) mutations in HBV genotype F during a follow-up study in chronic carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus HBx gene and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

HBx protein of hepatitis B virus activates Jak1-STAT signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Molecular functions and biological roles of hepatitis B virus x protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus x protein in the pathogenesis of hepatitis B virus‐induced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Functional inactivation but not structural mutation of p53 causes liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Dual effects of hepatitis B virus X protein on the regulation of cell-cycle control depending on the status of cellular p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Expression of hepatitis B virus X oncoprotein inhibits transcription-coupled nucleotide excision repair in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Caspase-dependent alterations of Ca2 signaling in the induction of apoptosis by hepatitis B virus X protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease Hepsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

The inhibition of apoptosis of hepatoma cells induced by HBx is mediated by up-regulation of survivin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Expression of fas ligand in human hepatoma cell lines: role of hepatitis-B virus X (HBX) in induction of Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

The carboxy-terminus of the hepatitis B virus X protein is necessary and sufficient for the activation of hypoxia-inducible factor-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Orcein staining of hepatitis B antigen in paraffin sections of liver biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Viral hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Hepatitis B virus replication induces methylation of both host and viral DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

Occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGR108

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGR108

1 reference

24 August 2017

1 reference